Prognostic significance of the C-reactive protein-albumin-lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy.

Matsunaga T, Saito H, Fukumoto Y, Kuroda H, Taniguchi K, Takahashi S, Osaki T, Iwamoto A, Fukuda K, Shimizu S, Shishido Y, Miyatani K, Sakamoto T, Fujiwara Y

Open source

DOI
10.1007/s00595-026-03296-y
Published
2026 Sep
Container
Surgery today
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00595-026-03296-y,
  title = {Prognostic significance of the C-reactive protein-albumin-lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy.},
  author = {Matsunaga T and Saito H and Fukumoto Y and Kuroda H and Taniguchi K and Takahashi S and Osaki T and Iwamoto A and Fukuda K and Shimizu S and Shishido Y and Miyatani K and Sakamoto T and Fujiwara Y},
  year = {2026},
  journal = {Surgery today},
  doi = {10.1007/s00595-026-03296-y},
  url = {https://doi.org/10.1007/s00595-026-03296-y}
}

RIS

TY  - JOUR
TI  - Prognostic significance of the C-reactive protein-albumin-lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy.
AU  - Matsunaga T
AU  - Saito H
AU  - Fukumoto Y
AU  - Kuroda H
AU  - Taniguchi K
AU  - Takahashi S
AU  - Osaki T
AU  - Iwamoto A
AU  - Fukuda K
AU  - Shimizu S
AU  - Shishido Y
AU  - Miyatani K
AU  - Sakamoto T
AU  - Fujiwara Y
PY  - 2026
JO  - Surgery today
DO  - 10.1007/s00595-026-03296-y
UR  - https://doi.org/10.1007/s00595-026-03296-y
ER  - 

APA

T, M., H, S., Y, F., H, K., K, T., S, T., T, O., A, I., K, F., S, S., Y, S., K, M., T, S., & Y, F. (2026). Prognostic significance of the C-reactive protein-albumin-lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy.. Surgery today. https://doi.org/10.1007/s00595-026-03296-y

Source records